Condition: Liver Cirrhosis · Cancer · Cachexia · Sponsor: Universitatsmedizin Mainz - 1. Medizinische Klinik
Frailty is a geriatric syndrome that primarily affects older patients, but also patients with severe illnesses. It is particularly common among oncology patients, but also among patients with gastrointestinal diseases such as liver cirrhosis or pancreatitis. Sarcopenia, a form of frailty, is defined as a loss of muscle quantity, quality and function. Currently, complex methods such as CT or bioimpedance measurement are available. However, simpler techniques such as ultrasound-based measurement could be alternatives, but still require further validation. In addition, serological muscle markers could support and simplify diagnostics. The aim of this project is to be able to estimate the prognosis of patients at an early stage by measuring sarcopenia using ultrasound and biomarkers.
This description comes directly from the study's public registry record.
Wolfgang Maximilian Kremer Kremer, MD · 00496131175711 · maximilian.kremer@unimedizin-mainz.de
Christian Labenz Labenz, MD · 0049 6131174209
Always discuss trial participation with your own doctor first.
| Universitatsmedizin Mainz | Mainz, Rhineland-Palatinate, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06829290